What monoclonal antibody is used to prevent respiratory syncytial virus (RSV) in high risk children?
A) Palivizumab
B) Natalizumab
C) Belimumab
D) Eculizumab
A
Feedback:
Palivizumab is specific to the antigenic site on respiratory syncytial virus (RSV); it inactivates that virus. It is used to prevent RSV disease in high-risk children. Natalizumab is an antibody specific to surface receptors on all leukocytes except neutrophils. Belimumab is a specific inhibitor of B-lymphocyte stimulator that inhibits the survival of B-lymphocytes and their differentiation into immune-globulin producing cells. Eculizumab binds to complement proteins and prevents the formation of the complement complex.
You might also like to view...
A nurse is teaching a group of high school students about risk factors for the development of cancer. The nurse explains that alcohol is the leading etiologic factor in developing cancer of the oral cavity, larynx, and esophagus
The nurse goes on to explain that when alcohol is combined with ___________, it increases the chances even more. 1. Tobacco 2. Spicy foods 3. Sweet foods 4. Soda
Mr. Jenkins has an IV of 2000 mg of lidocaine in 500 mL D5W started at 3 mg/min and titrated up at 1
mg/min based on heart rhythm. He has received a total of 150 mL of solution. How much lidocaine has he received? A. 60 mg B. 200 mg C. 150 mg D. 600 mg
The nurse recognizes that which patient would be most likely to develop hypovolemic shock? A patient with:
1. Decreased cardiac output 2. Severe constipation, causing watery diarrhea 3. Ascites 4. Syndrome of inappropriate ADH (SIADH)
You should tell the patient that you are counting his respirations.
Answer the following statement true (T) or false (F)